Key Points
AMRZ missed EPS by 33% but beat revenue by 2.4% in Q2 2026.
Earnings swung from $0.54 in Q1 to negative $0.16, showing sharp deterioration.
Operating margins compressed to 15.5% amid rising costs.
Analysts maintain Buy consensus with $74.90 yearly price target.
Amrize Ltd (AMRZ) reported Q2 2026 earnings on (May, 19, 2026), delivering a mixed quarter with revenue beating expectations but earnings falling short. The construction materials company posted revenue of $2.18 billion, exceeding the $2.13 billion estimate by 2.4%. However, AMRZ earnings per share came in at negative $0.16, missing the negative $0.12 forecast by 33%. The results highlight ongoing profitability challenges despite solid top-line growth.
AMRZ Earnings Preview: EPS and Revenue Expectations
Amrize Ltd earnings showed revenue strength but profit weakness in Q2 2026. The company generated $2.18 billion in sales, surpassing analyst expectations by $50 million. However, the EPS miss of $0.04 per share signals margin pressure in the building materials sector.
Compared to the prior quarter (Q1 2026), AMRZ earnings deteriorated significantly. Q1 posted EPS of $0.54 against a $0.59 estimate, while Q2 swung to negative $0.16. This represents a sharp earnings decline quarter-over-quarter.
Amrize Ltd Stock Valuation and Key Financial Metrics
AMRZ stock trades at $49.64 with a market cap of $27.43 billion and a PE ratio of 23.74. The company maintains a current ratio of 1.40, indicating adequate short-term liquidity. Operating margins compressed to 15.5% from prior levels, reflecting cost pressures.
Debt-to-equity stands at 0.51, showing moderate leverage. Free cash flow per share reached $2.38, though profitability metrics remain challenged. The stock has declined 22% over three months, underperforming broader market expectations.
What to Watch in Amrize Ltd Earnings Report
Investors should monitor gross margins, which fell to 25.4% in the latest period. Operating expenses grew 7.1% year-over-year, outpacing revenue growth of just 0.2%. This cost inflation is the primary driver of AMRZ earnings weakness.
The company’s inventory levels increased 11%, suggesting either demand softness or supply chain buildup. Days inventory outstanding rose to 64 days, indicating slower turnover in the construction materials market.
AMRZ Stock Forecast and Analyst Outlook
Analysts maintain a consensus rating of Buy with 19 buy ratings and 7 holds. Meyka AI rates AMRZ with a grade of B+, reflecting mixed fundamentals. The yearly price target stands at $74.90, implying 51% upside from current levels.
However, technical indicators show weakness. The RSI sits at 32.2, signaling oversold conditions, while the MACD remains negative. The stock faces near-term headwinds despite longer-term growth potential in construction materials demand.
Final Thoughts
AMRZ delivered a disappointing Q2 2026 earnings report with a 33% EPS miss despite beating revenue estimates. The negative earnings reflect margin compression and rising operating costs in the construction materials sector. While revenue growth remains positive, profitability deterioration is concerning. Investors should watch for management guidance on cost control and margin recovery in upcoming quarters. The B+ grade reflects balanced risk-reward, but near-term stock momentum appears challenged.
FAQs
Did AMRZ beat or miss earnings estimates?
AMRZ missed EPS by 33% (negative $0.16 vs. negative $0.12 estimate) but beat revenue by 2.4% in Q2 2026.
How did AMRZ Q2 2026 earnings compare to Q1?
Q2 earnings deteriorated significantly, swinging from $0.54 EPS in Q1 to negative $0.16, reflecting sharp profitability decline.
What is the AMRZ stock price target?
Analysts project $74.90 yearly price target (51% upside from current $49.64). Stock holds B+ grade from Meyka AI.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)